We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏
We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏
If you take care of patients with #HCC, do not miss this new update from BCLC
#liversky
@easlnews.bsky.social
www.journal-of-hepatology.eu/article/S016....
If you take care of patients with #HCC, do not miss this new update from BCLC
#liversky
@easlnews.bsky.social
www.journal-of-hepatology.eu/article/S016....
erictopol.substack.com/p/the-larges...
erictopol.substack.com/p/the-larges...
Anti-TIGIT tiragolumab does not add benefit to atezolizumab-bevacizumab for patients with advanced #HCC
#ESMOAmbassadors @myesmo.bsky.social
Anti-TIGIT tiragolumab does not add benefit to atezolizumab-bevacizumab for patients with advanced #HCC
#ESMOAmbassadors @myesmo.bsky.social
#ESMO25 #ESMOAmbassadors
@myesmo.bsky.social
#ESMO25 #ESMOAmbassadors
@myesmo.bsky.social
Learn more: https://www.aasld.org/2026-aasld-special-interest-group-sig-election-results
Learn more: https://www.aasld.org/2026-aasld-special-interest-group-sig-election-results
www.jhep-reports.eu/article/S258...
#Liversky
@easlnews.bsky.social
www.jhep-reports.eu/article/S258...
#Liversky
@easlnews.bsky.social
Trump administration officials will target Mexican Independence Day (Sept. 16) celebrations. @wttw.bsky.social
Trump administration officials will target Mexican Independence Day (Sept. 16) celebrations. @wttw.bsky.social
We now have 2 approved drugs with different MOA and that’s great news for patients. I anticipate at least 5 more approvals in the next 5 years.
#liversky
We now have 2 approved drugs with different MOA and that’s great news for patients. I anticipate at least 5 more approvals in the next 5 years.
#liversky
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
www.jci.org/articles/vie...
www.jci.org/articles/vie...
Registration here:
umich.cloud-cme.com/course/cours...
Registration here:
umich.cloud-cme.com/course/cours...
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter
Expert editorial by @laurennephewmd.bsky.social
journals.lww.com/hepcomm/full...
#liversky
1/
Expert editorial by @laurennephewmd.bsky.social
journals.lww.com/hepcomm/full...
#liversky
1/
We welcome you to share your memories and tributes to Josh here: bit.ly/412SOrs
Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging
#OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
https://buff.ly/419ebHP
#MedSky #OncSky #LiverSky @naultjc.bsky.social
Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging
#OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
Does the 💩 engraft?
Does the 💩 work (improved barrier function)?
This is why PPB is the future
journals.lww.com/hepcomm/full...
#liversky
Does the 💩 engraft?
Does the 💩 work (improved barrier function)?
This is why PPB is the future
journals.lww.com/hepcomm/full...
#liversky
✅️Review the imaging yourself
✅️Follow up if >5cm
✅️Biopsy for atypical appearance
journals.lww.com/hepcomm/fullte…
@jhepatology.bsky.socia#Liverskyk#GITwitterer
✅️Review the imaging yourself
✅️Follow up if >5cm
✅️Biopsy for atypical appearance
journals.lww.com/hepcomm/fullte…
@jhepatology.bsky.socia#Liverskyk#GITwitterer